Grisold W, Födinger M, Oberndorfer S
Neurologie und LBI Neuroonkologie, KFJ Spital, 1100 Wien, Osterreich.
Nervenarzt. 2010 Apr;81(4):418-22. doi: 10.1007/s00115-010-2952-5.
The coincidence of stroke and cancer is frequently encountered. From recent epidemiological data, the stroke risk in cancer patients seems to be equally distributed as compared to the non-cancer population. However, there are several clinical conditions in cancer patients which increase the risk for stroke: Trousseau's syndrome, non-bacterial thrombotic endocarditis and disseminated intravascular coagulation. Also some tumour-specific conditions such as coagulopathies, changes of viscosity and cellular mechanisms such as leukocytosis or thrombocytopathies must be considered. In several types of tumour treatment, such as various anticancer drugs, an increased occurrence of stroke has been reported. Presently there is no indication that stroke and cancer are related to the immune-mediated "classic" paraneoplastic syndromes. However, there are several cancer-specific types and causes of stroke which need to be considered in each patient, as they can be of significance in the treatment.
中风与癌症的并发情况屡见不鲜。从近期的流行病学数据来看,癌症患者的中风风险与非癌症人群相比似乎分布相当。然而,癌症患者存在多种临床情况会增加中风风险:特鲁索综合征、非细菌性血栓性心内膜炎和弥散性血管内凝血。此外,还必须考虑一些肿瘤特异性情况,如凝血障碍、血液黏稠度变化以及诸如白细胞增多或血小板病等细胞机制。在几种肿瘤治疗方式中,如使用各种抗癌药物,已有报道称中风的发生率会增加。目前没有迹象表明中风与癌症与免疫介导的“经典”副肿瘤综合征有关。然而,有几种癌症特异性的中风类型和病因需要在每位患者中加以考虑,因为它们在治疗中可能具有重要意义。